Collectively, these studies prompt questions in relation to the presentation of β cell autoantigens to CD8+ T cells by HLA‐B*39‐ and HLA‐A*24‐encoded HLA class I molecules and the potential of these events to drive β cell destruction and accelerate type 1 diabetes progression. This evidence concerns the gene CD8A and type 1 diabetes mellitus.